GlassScriptPhysician profile
Randy J Rice
NPI 1083652275
$383.61
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.54 · 2021: $84.18 · 2022: $61.52 · 2023: $112 · 2024: $48.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $160.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $70.31 | 2023 | Impella |
| Pfizer INC. | $48.92 | 2019-2021 | |
| Abbvie INC. | $35.52 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $34.84 | 2021 | |
| Astellas Pharma US INC | $32.43 | 2019-2023 | Veozah |
| Astrazeneca Pharmaceuticals LP | $27.27 | 2022 | |
| Daiichi Sankyo INC. | $25.12 | 2022 | |
| Tempus Ai, INC | $24.25 | 2024 | |
| Xeris Pharmaceuticals, INC. | $21.92 | 2023 | Keveyis |
| Allergan, INC. | $17.90 | 2019 | |
| Collegium Pharmaceutical, INC. | $13.48 | 2019 | |
| Sanofi Pasteur INC. | $11.32 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.20 | 2019 | |
| Organon LLC | $9.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.